Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Core Phase - up to Week 48	STARTED	Osilodrostat Group	48
Core Phase - up to Week 48	STARTED	Osilodrostat Placebo Group	25
Core Phase - up to Week 48	COMPLETED	Osilodrostat Group	42
Core Phase - up to Week 48	COMPLETED	Osilodrostat Placebo Group	23
Core Phase - up to Week 48	NOT COMPLETED	Osilodrostat Group	6
Core Phase - up to Week 48	NOT COMPLETED	Osilodrostat Placebo Group	2
Optional Extension Phase	STARTED	Osilodrostat Group	38
Optional Extension Phase	STARTED	Osilodrostat Placebo Group	22
Optional Extension Phase	COMPLETED	Osilodrostat Group	33
Optional Extension Phase	COMPLETED	Osilodrostat Placebo Group	20
Optional Extension Phase	NOT COMPLETED	Osilodrostat Group	5
Optional Extension Phase	NOT COMPLETED	Osilodrostat Placebo Group	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02697734/flow